You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
東陽光藥(01558.HK)旗下三種藥品中標第二批全國藥品集中採購
格隆匯 01-17 22:10

格隆匯1月17日丨東陽光藥(01558.HK)宣佈,於2020年1月17日,公司參加了國家組織藥品集中採購和使用聯合採購辦公室(以下簡稱"聯合採購辦公室")組織的第二批國家組織藥品集中採購的投標。公司的福多司坦片以及公司全資子公司東莞市陽的康醫藥有限責任公司的鹽酸莫西沙星片、奧美沙坦酯片中標此次集中採購。

福多司坦片、鹽酸莫西沙星片和奧美沙坦酯片的適應症所對應的市場空間廣大,隨着三個品種藥品價格下降,其在患者中的滲透率提高,藥品銷售量有望大幅上升,市場潛力巨大。公司後續簽訂採購合同並實施後,將迅速提高公司在三個品種市場中的佔有率,擴大相關產品的銷售,促進公司國內市場的開拓,提升公司的品牌影響力,公司的收入結構也能得到改善,對公司的未來經營業績產生積極的影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account